High prevalence of circulating myositis-associated antibodies in non-COVID critical illness - 24/04/24
Doi : 10.1016/j.resmer.2024.101088
Alyssa Soskis a, 1, Mary B. Rice a, Donald B. Bloch b, Rachel K. Putman c, Antonio Arciniegas Rubio c, Katherin Zambrano Vera c, Rene S. Bermea b, Andrew J. Sauer b, Claire O. Sinow b, Max Shen a, Mayra Pinilla Vera c, Rebecca M. Baron c, Robert W. Hallowell b, ⁎ 
a Beth Israel Deaconess Medical Center, Boston, MA, USA
b Massachusetts General Hospital, Boston, MA, USA
c Brigham and Women's Hospital, Boston, MA, USA
⁎Corresponding author.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Keywords : Acute respiratory distress syndrome, Myositis, Autoantibodies, COVID-19, Interstitial lung disease
Plan
| Funding sources: The Sidney and Deanna Wolk Family Fund for Translational Research in Interstitial Lung Disease; Luisa Hunnewell; Larry Newman and The Feil Family Foundation. |
© 2024
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 85
Article 101088- juin 2024 Retour au numéro
Article précédent
- Efficacy and safety of different inhaled corticosteroids for bronchopulmonary dysplasia prevention in preterm infants: A systematic review and meta-analysis
- Minghai Zhang, Wei Zhang, Hongqun Liao
- Comparison of ChatGPT version 3.5 & 4 for utility in respiratory medicine education using clinical case scenarios
- Gayathri Balasanjeevi, Krishna Mohan Surapaneni
Bienvenue sur EM-consulte, la référence des professionnels de santé.